Filter your results
- 2
- 1
- 3
- 2
- 2
- 1
- 3
- 2
- 2
- 2
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insightsAnnals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles
hal-03623367v1
|
||
Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the SFGM-TC.Haematologica, 2013, 98, pp.776-783
Journal articles
hal-00766808v1
|
|||
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insightsAnnals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles
hal-03376715v1
|